Becton Dickinsonvs.Stryker
BDX vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Stryker is about 2.2× larger than Becton Dickinson by market cap; Stryker trades at the lower P/E (28.7 vs 52.7); year to date, Becton Dickinson leads (+19.8% vs −21.2%).
Side by side
| BDX | SYK | |
|---|---|---|
| Market cap | $49.7B | $107B |
| Price | $183.75 | $277.33 |
| Today | +0.5% | +0.1% |
| Return YTD | +19.8% | −21.2% |
| Return 1Y | +19.9% | −26.2% |
| Since June 26, 2026 | +17.8% | −16.6% |
| P/E | 52.7 | 28.7 |
| P/S | 2.4 | 4.1 |
| P/B | 2.0 | 4.5 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Becton DickinsonBDX
Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.
Full BDX profile →StrykerSYK
Orthopaedic implants and surgical equipment, with Mako bringing robot assistance into the operating room.
Full SYK profile →More BDX & SYK comparisons
Other head-to-heads in the Medtech & devices segment.